Role of osteopontin in dendritic cell shaping of immune responses.


Journal

Cytokine & growth factor reviews
ISSN: 1879-0305
Titre abrégé: Cytokine Growth Factor Rev
Pays: England
ID NLM: 9612306

Informations de publication

Date de publication:
12 2019
Historique:
received: 15 04 2019
accepted: 09 05 2019
pubmed: 28 5 2019
medline: 24 7 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

Osteopontin (OPN) is a pleiotropic cytokine produced both by immune and non-immune cells and active on different cellular targets. OPN production has been associated with several pathological conditions, including autoimmune diseases (e.g. lupus, multiple sclerosis and rheumatoid arthritis) and cancer. Emerging evidence suggests that the role of OPN has been underestimated, as it seems to be working at multiple levels of immune regulation, such as the shaping of T cell effector responses, the regulation of the tumor microenvironment, and the functional interaction with mesenchymal stromal cells. In this context, dendritic cells (DCs) play a crucial role being both an important source and a cellular target for OPN action. DC family is composed by several cell subsets endowed with specific immune functions. OPN exerts its biological functions through multiple receptors and is produced in different intracellular and secreted forms. OPN production by DC subsets is emerging as a crucial mechanism of regulation in normal and pathological conditions and starts to be exploited as a therapeutic target. This review will focus on the role of DC-derived OPN in shaping immune response and on the complex role of this cytokines in the regulation in immune response.

Identifiants

pubmed: 31126876
pii: S1359-6101(19)30054-1
doi: 10.1016/j.cytogfr.2019.05.004
pii:
doi:

Substances chimiques

Cytokines 0
Osteopontin 106441-73-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-28

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Annalisa Del Prete (A)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy; Humanitas Clinical and Research Center-IRCCS Rozzano-Milano, Italy.

Sara Scutera (S)

Microbiology section, Department of Public Health and Pediatric Sciences, University of Torino, Turin, Italy.

Silvano Sozzani (S)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. Electronic address: silvano.sozzani@unibs.it.

Tiziana Musso (T)

Microbiology section, Department of Public Health and Pediatric Sciences, University of Torino, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH